Monash Ivf Group Ltd (MVF) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.051x

Based on the latest financial reports, Monash Ivf Group Ltd (MVF) has a cash flow conversion efficiency ratio of 0.051x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$13.13 Million ≈ $9.29 Million USD) by net assets (AU$257.95 Million ≈ $182.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MVF net asset quality score to measure how much of total assets are equity-financed.

Monash Ivf Group Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Monash Ivf Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Monash Ivf Group Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Monash Ivf Group Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Monash Ivf Group Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Invesco Pennsylvania Value Municipal Income Trust NYSE:VPV	0.021x
Jindal Drilling And Industries Limited NSE:JINDRILL	0.135x
Coastal Contracts Bhd KLSE:5071	-0.027x
Lightron Inc. KQ:069540	-0.041x
Newbury Street II Acquisition Corp Class A Ordinary Shares NASDAQ:NTWO	-0.002x
Ampco-Pittsburgh Corporation NYSE:AP	0.035x
Bank Woori Saudara Indonesia 1906 JK:SDRA	-0.049x
Josef Manner & Comp. AG VI:MAN	-0.119x

Annual Cash Flow Conversion Efficiency for Monash Ivf Group Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Monash Ivf Group Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Monash Ivf Group Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$250.42 Million ≈ $177.19 Million	AU$12.90 Million ≈ $9.13 Million	0.052x	-75.80%
2024-06-30	AU$246.66 Million ≈ $174.53 Million	AU$52.52 Million ≈ $37.16 Million	0.213x	+49.71%
2023-06-30	AU$275.07 Million ≈ $194.63 Million	AU$39.12 Million ≈ $27.68 Million	0.142x	+20.37%
2022-06-30	AU$269.89 Million ≈ $190.97 Million	AU$31.89 Million ≈ $22.56 Million	0.118x	-27.88%
2021-06-30	AU$268.44 Million ≈ $189.94 Million	AU$43.98 Million ≈ $31.12 Million	0.164x	+32.90%
2020-06-30	AU$252.12 Million ≈ $178.39 Million	AU$31.08 Million ≈ $21.99 Million	0.123x	-35.40%
2019-06-30	AU$173.43 Million ≈ $122.72 Million	AU$33.09 Million ≈ $23.42 Million	0.191x	+22.79%
2018-06-30	AU$166.86 Million ≈ $118.06 Million	AU$25.93 Million ≈ $18.35 Million	0.155x	-1.92%
2017-06-30	AU$163.52 Million ≈ $115.70 Million	AU$25.91 Million ≈ $18.33 Million	0.158x	-44.43%
2016-06-30	AU$154.88 Million ≈ $109.58 Million	AU$44.16 Million ≈ $31.25 Million	0.285x	+14.05%
2015-06-30	AU$144.03 Million ≈ $101.91 Million	AU$36.01 Million ≈ $25.48 Million	0.250x	-13.85%
2014-06-30	AU$124.82 Million ≈ $88.32 Million	AU$36.22 Million ≈ $25.63 Million	0.290x	+145.23%
2013-06-30	AU$-46.92 Million ≈ $-33.20 Million	AU$30.11 Million ≈ $21.30 Million	-0.642x	--

About Monash Ivf Group Ltd

AU:MVF Australia Diagnostics & Research

Market Cap

$192.98 Million

AU$272.74 Million AUD

Market Cap Rank

#16682 Global

#469 in Australia

Share Price

AU$0.70

Change (1 day)

+0.00%

52-Week Range

AU$0.59 - AU$0.88

All Time High

AU$1.65